Ticagrelor is an oral antiplatelet medication used to reduce the risk of cardiovascular events like heart attacks and strokes in patients with acute coronary syndrome or a history of myocardial infarction. It works by reversibly inhibiting the P2Y12 receptor on platelets, preventing aggregation and subsequent clot formation more effectively than some other antiplatelet drugs like clopidogrel.